by MM360 Staff | May 31, 2025 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | May 31, 2025 | Myeloma News
Source: Pharmacy Times articles IVIG treatment significantly boosts platelet counts in pregnant people with thrombocytopenia, revealing key predictors for effective response and optimizing clinical decisions. Read More
by MM360 Staff | May 31, 2025 | Uncategorized
Source: CureToday articles Among patients with ESR1-mutant, ER+, HER2– advanced breast cancer, vepdegestrant improved survival without progression when compared with Faslodex. Read More
by MM360 Staff | May 31, 2025 | Uncategorized
Source: CureToday articles Second-line Enhertu improved key survival end points versus Cyramza plus paclitaxel for HER2+ gastric cancer or gastroesophageal junction adenocarcinoma. Read More
by MM360 Staff | May 31, 2025 | Uncategorized
Source: CureToday articles Trodelvy plus Keytruda, when given in the frontline, extended survival without progression versus chemo plus Keytruda in PD-L1+ metastatic TNBC. Read More